UBS lowered the firm’s price target on Altria Group to $39.20 from $40.40 and keeps a Sell rating on the shares ahead of the October 26 earnings report. The firm expects to see continued pressure on Altria’s portfolio, and the broader tobacco market, for Q3 and Q4, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on MO:
- Altria Group put volume heavy and directionally bearish
- Philip Morris Stock (NYSE:PM) Gets Dividend Hike. Should You Buy?
- Unusually active option classes on open September 6th
- FDA tells CNN menthol ban to be finalized ‘in the coming months’
- Jefferies says British American among ‘biggest beneficiaries’ of FDA delay